On Monday, Candel Therapeutics Inc (NASDAQ: CADL) was -9.13% drop from the session before settling in for the closing price of $6.35. A 52-week range for CADL has been $4.25 – $13.68.
Healthcare Sector giant saw their annual sales slid by -43.86% over the last five years. When this article was written, the company’s average yearly earnings per share was at 76.06%. With a float of $41.06 million, this company’s outstanding shares have now reached $54.90 million.
Candel Therapeutics Inc (CADL) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Candel Therapeutics Inc stocks. The insider ownership of Candel Therapeutics Inc is 25.21%, while institutional ownership is 36.98%. The most recent insider transaction that took place on Jul 28 ’25, was worth 6,540. In this transaction Chief Medical Officer of this company sold 937 shares at a rate of $6.98, taking the stock ownership to the 52,493 shares. Before that another transaction happened on Jun 30 ’25, when Company’s Chief Medical Officer sold 781 for $5.04, making the entire transaction worth $3,936. This insider now owns 52,493 shares in total.
Candel Therapeutics Inc (CADL) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.23 earnings per share (EPS) during the time that was better than consensus figure (set at -0.23) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.44% during the next five years compared to -43.86% drop over the previous five years of trading.
Candel Therapeutics Inc (NASDAQ: CADL) Trading Performance Indicators
You can see what Candel Therapeutics Inc (CADL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.56, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.99 in one year’s time.
Technical Analysis of Candel Therapeutics Inc (CADL)
Analysing the last 5-days average volume posted by the [Candel Therapeutics Inc, CADL], we can find that recorded value of 1.62 million was better than the volume posted last year of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 74.03%.
During the past 100 days, Candel Therapeutics Inc’s (CADL) raw stochastic average was set at 52.79%, which indicates a significant decrease from 57.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.40 in the past 14 days, which was higher than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.29, while its 200-day Moving Average is $5.68. Now, the first resistance to watch is $6.27. This is followed by the second major resistance level at $6.77. The third major resistance level sits at $7.03. If the price goes on to break the first support level at $5.50, it is likely to go to the next support level at $5.24. Now, if the price goes above the second support level, the third support stands at $4.74.
Candel Therapeutics Inc (NASDAQ: CADL) Key Stats
There are 54,898K outstanding shares of the company, which has a market capitalization of 316.76 million. As of now, sales total 0 K while income totals -55,180 K. Its latest quarter income was 0 K while its last quarter net income were -11,270 K.
